JP Morgan Chase
MTCR

JP Morgan Chase’s Metacrine, Inc. Common Stock MTCR Stock Holding History

JP Morgan Chase’s Portfolio MTCR Stock Details MTCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3
Closed – – 7259
2022
Q3 		$0 Buy
+3
New +$1 ﹤0.01% 7075
2022
Q2 		– Sell
-1,038
Closed -$1K – 7117
2022
Q1 		$1K Buy
+1,038
New +$544 ﹤0.01% 6520
2021
Q3 		– Sell
-883
Closed -$3K – 6967
2021
Q2 		$3K Sell
883
-312,183
-100% -$1.29M ﹤0.01% 6190
2021
Q1 		$1.94M Buy
313,066
+240,950
+334% +$2.13M ﹤0.01% 3750
2020
Q4 		$566K Buy
+72,116
New +$661K ﹤0.01% 4295

Other funds holding MTCR

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase's MTCR Position: Q4 2022 in Review

JP Morgan Chase sold out of Metacrine, Inc. Common Stock (MTCR) in Q4 2022, closing a stake of 3 shares.

JP Morgan Chase first reported a position in MTCR in Q4 2020 and held it in 5 quarters. The position peaked at $1.94M in Q1 2021. 29 funds tracked by Wall St. Rank hold MTCR as of Q4 2022.

  • JP Morgan Chase reported no remaining Metacrine, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Chase sold 3 Metacrine, Inc. Common Stock shares in Q4 2022.
  • JP Morgan Chase first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • JP Morgan Chase's Metacrine, Inc. Common Stock position peaked at $1.94M in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q4 2022.

Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.